2m 2m 2m 2m 2m 2m 2m
HIGH TIDE (HITI)
NASDAQ
$2.35-$0.04 (-1.88%)
Price as of Jun 03, 2026 6:51 PM EDT- $215.3MMarket Cap
- 4.82%1-Year Change
- Pharmaceutical RetailersIndustry
HIGH TIDE (HITI)
$2.35-$0.04 (-1.88%)
Annual
Quarterly
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 594.0M +13.72% | 522.3M +7.10% | 487.7M +36.66% | 356.9M +97.02% | |
Cost of Revenue | 439.6M +15.74% | 379.8M +6.58% | 356.4M +39.26% | 255.9M +118.46% | |
Gross Profit | 153.5M +7.74% | 142.5M +8.52% | 131.3M +30.08% | 101.0M +57.78% | |
Sales and Marketing Expense | 3.2M -23.55% | 4.2M +0.53% | 4.1M -47.33% | 7.9M +128.46% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 24.3M -4.26% | 25.4M -22.49% | 32.8M +8.59% | 30.2M +28.02% | |
Total Operating Expenses | 26.1M +19.31% | 21.8M -18.79% | 26.9M +3.52% | 26.0M +69.46% | |
Operating Profit | -14.4M -388.79% | 5.0M +112.08% | -41.4M -42.71% | -72.3M +287.22% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.3M +766.67% | -150,000 N/A | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -1.3M +766.67% | -150,000 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 1.3M +766.67% | 150,000 N/A | |
Income before Taxes | -51.4M +1,248.83% | -3.8M -90.69% | -41.0M -42.20% | -70.8M +102.21% | |
Income Taxes | -25,000 -95.78% | -593,000 -92.24% | -7.6M +162.23% | -2.9M +299.32% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -51.4M +1,248.83% | -3.8M -90.69% | -41.0M -42.20% | -70.8M +102.21% | |
Net Income from Continuing Operations Applicable to Common | -51.4M +1,248.83% | -3.8M -90.69% | -41.0M -42.20% | -70.8M +102.21% | |
Basic EPS and Net Income | -0.62 +1,140.00% | -0.05 -90.57% | -0.53 -53.51% | -1.14 +35.71% | |
Diluted EPS and Net Income | -0.62 +1,140.00% | -0.05 -90.57% | -0.53 -53.91% | -1.15 +36.90% | |
Basic Weighted Average Shares | 82.2M +3.30% | 79.6M +7.03% | 74.3M +18.40% | 62.8M +47.94% | |
Diluted Weighted Average Shares | 82.2M +3.30% | 79.6M +7.03% | 74.3M +18.40% | 62.8M +47.94% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 47.9M +1.30% | 47.3M +56.92% | 30.1M +20.08% | 25.1M +78.99% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 47.9M +1.30% | 47.3M +56.92% | 30.1M +20.08% | 25.1M +78.99% | |
Total Current Assets | 136.9M +59.56% | 85.8M +24.97% | 68.6M +7.16% | 64.1M +38.40% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 29.4M +7.15% | 27.5M +1.21% | 27.1M -13.79% | 31.5M +27.17% | |
Total Long-Term Assets | 212.2M +32.26% | 160.4M -2.63% | 164.8M -21.80% | 210.7M +5.38% | |
Total Assets | 349.1M +41.78% | 246.2M +5.49% | 233.4M -15.05% | 274.7M +11.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 16.2M +25.58% | 12.9M -20.14% | 16.1M -1.54% | 16.4M N/A | |
Total Current Liabilities | 99.9M +62.52% | 61.5M +5.75% | 58.1M -3.01% | 59.9M +46.96% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 146.4M +273.20% | 39.2M -5.73% | 41.6M -21.17% | 52.8M -1.23% | |
Total Liabilities | 246.3M +144.57% | 100.7M +0.96% | 99.7M -11.51% | 112.7M +19.64% | |
Retained Earnings | -260.1M +24.24% | -209.4M +1.66% | -205.9M +22.51% | -168.1M +91.47% | |
Total Stockholders Equity | 102.8M -29.36% | 145.5M +8.86% | 133.7M -17.51% | 162.0M +6.60% | |
Total Shares Outstanding | 87.5M +8.29% | 80.8M +7.29% | 75.3M +63.50% | 46.1M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 23.9M -32.86% | 35.5M +72.04% | 20.7M +359.64% | 4.5M +259.12% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -22.3M +102.43% | -11.0M +92.62% | -5.7M -33.47% | -8.6M -69.85% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 202,000 +102.62% | -7.7M -16.62% | -9.3M -161.07% | 15.2M -59.88% | |
Financials Ratio | |||||
Gross Margin | 25.99% -4.73% | 27.28% +1.32% | 26.93% -4.82% | 28.29% N/A | |
Operating Margin | -2.43% -353.93% | 0.96% +111.28% | -8.49% -58.08% | -20.26% N/A | |
Return on Assets | -17.27% +986.76% | -1.59% -90.14% | -16.12% -40.74% | -27.20% N/A | |
Return on Equity | -41.40% +1,416.55% | -2.73% -90.14% | -27.70% -38.61% | -45.12% N/A | |
Revenue Growth | 13.72% +93.22% | 7.10% -80.63% | 36.66% -62.22% | 97.02% N/A | |
Current Ratio | 1.37 -1.82% | 1.40 +18.18% | 1.18 +10.48% | 1.07 N/A | |
Cash Ratio | 0.48 -37.67% | 0.77 +48.39% | 0.52 +23.80% | 0.42 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow